IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $591,128 | +7.1% | 61,384 | +18.3% | 0.05% | +11.4% |
Q2 2023 | $551,865 | -76.3% | 51,867 | -76.6% | 0.04% | -77.0% |
Q1 2023 | $2,327,960 | -10.5% | 221,289 | +5.4% | 0.19% | -12.4% |
Q4 2022 | $2,601,268 | +614.6% | 209,949 | +498.1% | 0.22% | +603.2% |
Q3 2022 | $364,000 | – | 35,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
EMC Capital Management | 43,315 | $417 | 0.31% |